Student Health Care Center
Gainesville, Florida, 32610, United States
NCT Number: NCT01289873
The purpose of this study is to determine how common oral HPV infections are in college women. The investigators also will find out what risk factors are associated with having oral HPV infections. The investigators hypothesize that approximately 3% of women will have oral HPV, and that HPV will be associated with oral sexual behaviors and with smoking behaviors. Finally, for those women with oral HPV- the investigators will determine whether the infections are persistent (still present) at 3-, 6-, and 12-months after the initial diagnosis.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Gainesville, Florida, 32610, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at enrollment
any oral HPV at enrollment
Time frame: 1 year
Determine whether HPV remains present at 3-months, 6-months, and 12-months after enrollment
University of Florida
Other
Prevalence, Persistence, and Risk Factors for Oral HPV Infections in College Women
Acronym: HOP-IN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06519994
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kisumu, Kenya
View Trial DetailsNCT07418203
Human Papillomavirus
Reims, France
View Trial DetailsNCT05413811
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Westdene, Johannesburg, South Africa
View Trial DetailsNCT02236273
Human Papillomavirus
New York, United States
View Trial Details